🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this trial is to assess the effects of cytisinicli...
Status
Completed
Location
BlueClinical Phase I
Start Date
2022-10-17
Trial ID
NCT05566288
Treatments Being Tested
This is a phase 3 double-blind, randomized, placebo-controlled, study to as...
Status
Recruiting
Location
First Affiliated Hospital of Soochow University
Start Date
2021-06-07
Trial ID
NCT04853342
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of naldeme...
Status
Completed
Location
Shionogi Research Site
Start Date
2013-11-04
Trial ID
NCT01993940
Treatments Being Tested
The main purpose of this study is to assess the safety and tolerability of ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-06
Trial ID
NCT01870297
Treatments Being Tested
This is a phase 3 clinical study conducted in China. The primary objective ...
Status
Not Yet Recruiting
Location
China-Japan Friendship Hospital
Start Date
2026-08-31
Trial ID
NCT07719023
Treatments Being Tested
Compare the effect of exenatide (therapeutic and supratherapeutic concentra...
Status
Completed
Location
Research Site
Start Date
2011-02
Trial ID
NCT01297062
Treatments Being Tested
Persistent viral infection with viral reservoirs and detection of circulati...
Status
Active Not Recruiting
Location
UCSF/Zuckerberg San Francisco General Hospital
Start Date
2024-04-09
Trial ID
NCT06161688
Treatments Being Tested
This is a single-center, randomized, double-blinded, placebo-controlled, pa...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-12-09
Trial ID
NCT04109742
Treatments Being Tested
The purpose of the study is to learn about the safety of MK-2225, including...
Status
Completed
Location
Clinical Pharmacology of Miami (Site 0002)
Start Date
2023-11-21
Trial ID
NCT06643390